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Abstract
Background/Objectives Successful pregnancy requires the de novo creation of low-resistance utero-placental and feto-
placental circulations and incomplete remodeling of this vasculature can lead to maternal or fetal compromise. Maternal BMI
and fetal sex are known to influence vascular compliance and placental development, but it is unknown if these are
independent or synergistic effects. Here we aim to investigate the impact of maternal obesity, fetal sex, and any interaction
thereof on maternal cardiovascular adaptation to pregnancy, by assessing the physiological drop of uterine artery doppler
pulsatility (UtA-PI) and umbilical artery doppler pulsatility index (UA-PI) over gestation.
Subjects/Methods Nulliparous women with a singleton pregnancy participating in a prospective cohort study (n= 4212)
underwent serial UtA-PI and UA-PI measurements at 20-, 28- and 36-weeks gestation. Linear mixed regression models were
employed to investigate the influence of maternal BMI, fetal sex and interactions thereof on the magnitude of change in
UtA-PI and UA-PI.
Results Throughout gestation, UtA-PI was higher for male fetuses and UA-PI was higher for female fetuses. The phy-
siological drop of UtA-PI was significantly smaller in overweight (change −24.3% [95%CI −22.3, −26.2]) and obese
women (change −21.3% [−18.3, −24.3]), compared to normal-weight women (change −25.7% [−24.3, −27.0]) but did not
differ by fetal sex. The physiological drop in UA-PI was greater for female than male fetuses (–32.5% [−31.5, −33.5] vs.
−30.7% [−29.8, −31.7]) but did not differ by maternal BMI. No interactions between maternal BMI and fetal sex
were found.
Conclusions Maternal cardiovascular adaptation to pregnancy is independently associated with maternal BMI and fetal sex.
Our results imply sexual dimorphism in both maternal cardiovascular adaptation and feto-placental resistance.
Introduction
Successful pregnancy requires the de novo creation of low-
resistance utero-placental and feto-placental circulations.
Incomplete remodeling of the maternal spiral arteries or
failure to form a sufficiently low-resistance placental cir-
culation results in fetal and maternal compromise, and
subsequent adverse outcomes, including pre-eclampsia
[1–3] and fetal growth restriction [3–5]. Doppler ultra-
sonography can be used in pregnancy to assess the utero-
placental and feto-placental circulation, with the uterine
artery doppler pulsatility index (PI) reflecting vascular
resistance on the maternal side of the placental circulation
and the umbilical artery PI reflecting the vascular resistance
on the fetal side of the placenta [6, 7].
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In the non-pregnant state, obesity impairs vascular
compliance and is associated with increased arterial stiff-
ness [8, 9]. In pregnancy, high maternal BMI is associated
with increased systolic blood pressure, increased left ven-
tricular mass, and higher stroke volume [10–12], even in
pregnant obese women without perinatal complications
[13, 14]. Women with a higher BMI have a ‘dose-depen-
dent’ increased risk of incomplete spiral artery conversion
during pregnancy, which is likely to impair the formation
of an appropriately low-resistance utero-placental circula-
tion [15].
Fetal sex is also increasingly recognized as a key
modulator of both placental development and maternal
adaptation to pregnancy [16–18]. Recent evidence sug-
gests that fetal sex differences influence the production of
maternal angiogenic and fibrinolytic factors, which in turn
can influence placental angiogenesis and spiral artery
remodeling [19]. Broere-Brown and colleagues observed
sex differences in ultrasonographic measurements of
maternal vascular resistance; women pregnant with a male
fetus had higher uterine artery pulsatility index (UtA-PI)
in the second and third trimester compared to women
carrying a female fetus [20]. Further evidence suggests
that the umbilical artery pulsatility index (UA-PI) is
higher in pregnancies where the fetus is female compared
to male [21].
The aim of the present study was to define the long-
itudinal impact of maternal BMI and fetal sex on resistance
in the utero-placental and feto-placental circulation, and in
particular whether these are synergistic or independent
factors. Crucially, both of these factors can vary between
different pregnancies in the same woman. BMI changes
between subsequent pregnancies are relatively common and
alter the risk of an adverse pregnancy outcome [22]. Fetal
sex is determined as-if-at-random for each pregnancy and is
also an important influence on pregnancy success [23, 24].
Our findings may therefore help to explain variability in
pregnancy complications experienced by women in suc-
cessive pregnancies.
Subjects and methods
Study design
The Pregnancy Outcome Prediction (POP) study was a
prospective cohort study of nulliparous primiparous women
attending the Rosie Hospital, Cambridge (UK) for their
dating scan (11–14 weeks) between January 14, 2008 and
July 31, 2012. Women with a viable singleton pregnancy
were eligible for inclusion. The study protocol has pre-
viously been described in detail [25]. Ethical approval for
the study was obtained from the Cambridgeshire 2 Research
Ethics Committee (reference number 07/H0308/163).
Written informed consent was given by all participants.
Women participating in this study underwent serial research
ultrasound scans at 20, 28, and 36 weeks of gestation, with
both the woman and the clinician blinded to the result of
the scans.
Doppler measurements
The uterine artery pulsatility index (UtA-PI) was assumed
to reflect the resistance in the utero-placental circulation and
thus the efficacy of spiral artery remodeling [1], with a
higher UtA-PI indicating narrow and stiff spiral arteries
[26]. The umbilical artery pulsatility index (UA-PI) was
assumed to primarily reflect resistance in the feto-placental
circulation (although it will also depend on fetal cardiac
function [27, 28]).
Definitions
Body mass index (BMI) was calculated from maternal
weight and height measured on the day of the booking scan
and was used as proxy for pre-pregnancy BMI. Maternal
BMI categories were based on the WHO BMI categories,
with BMI < 18.5 classified as underweight, BMI 18.5–24.99
as normal weight, BMI 25–29.99 as overweight and BMI ≥
30 as obese. Research ultrasound scans were conducted at
20, 28 and 36 weeks of gestation. The management and
analysis of the ultrasound data have been described in detail
previously [29]. Maternal age was defined as age at
recruitment. Ethnicity was self-reported via a questionnaire
at the 20-week scan. Gestational age was based on the
estimation at time of the first scan. The cut off values for
clinically relevant reference ranges of the PI indices used
were (i) uterine artery PI > 95th centile at 20 wkGA (ii)
umbilical artery PI > 95th centile at 28 wkGA and (iii)
umbilical artery PI > 95th centile at 36 wkGA.
Data analysis
Linear mixed regression analyses were used to model the
repeat absolute log-transformed UtA-PI or UA-PI mea-
surements to assess the changes in UtA-PI or UA-PI levels
over gestation. The linear mixed models included a random
intercept per woman, fixed effects for BMI category and/or
fetal sex (and interactions thereof) at the estimated gesta-
tional age at each research scanning time (i.e., 20, 28 or
36 weeks). Further adjustment was made for maternal sys-
tolic blood pressure measured at 12 weeks, maternal eth-
nicity, maternal age, marital status, maternal smoking status
and deprivation index. Covariates were selected based on
clinical relevance. The model used to estimate the unad-
justed log-transformed levels of UtA-PI over gestation by
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BMI categories can be represented as:
log UtA PIij
  ¼ NORMALWEIGHTi 
X3
j¼1
β0jdij þ OVERWEIGHTi

X3
j¼1
β1jdij þ OBESEi 
X3
j¼1
β2jdij
where di1 equals the estimated gestational age at the 20-
week scan minus 20, di2 represents the estimated gestational
age at the 28-week minus 28 and di3 represents the
estimated gestational age at the 36-week minus 36; ui
represents the random intercept and eij represents residual
error for individual i and scanning time j for j= 1,…,3. This
parameterization allows easy interpretation, for example,
β11, β12 and β13 represent the log-transformed values in
UtA-PI at exactly 20, 28 or 36 weeks, respectively for
normal-weight women.
As a sensitivity analysis, we repeated the analyses to (i)
include glucose measurement at 28 weeks, (ii) add gesta-
tional weight gain as covariates and (iii) exclude women
who experienced any perinatal complication during preg-
nancy (gestational diabetes, preeclampsia, gestational
hypertension or preterm birth).
Statistical analyses were performed using R [30] with the
lme4 package [31] for performing mixed linear models.
Figures were produced using the ggplot2 package [32].
Results
A total of 4512 women participated in the POP study, with
300 women lost to follow up. For this analysis, we excluded
women with missing information on maternal BMI and/or
fetal sex (n= 19), with a stillbirth or miscarriage (n= 33),
with missing covariates (n= 351) and who were under-
weight (n= 67), since the underweight group was under-
powered for inference (Fig. 1). A total of 3742 women were
included in the analyses, of whom 57.8% had a normal
weight (BMI 18.5–24.9 kg/m2), 28.3% were overweight
(BMI 25.0–29.9 kg/m2), and 13.9% were classified as obese
(BMI ≥ 30.0 kg/m2) (Table 1). Women with higher maternal
BMI were more likely to be smokers, and have pre-existing
and gestational hypertension, as well as preeclampsia and
gestational diabetes. Neonates born to overweight and obese
women were more likely to have higher birthweight and
placental weight compared to babies born to normal-weight
women (Table 1). There were no significant differences in
maternal baseline characteristics or perinatal complications
between fetal sexes. Male neonates had on average about
125 g higher birthweight compared to female neonates
(Supplementary Table 1).
The absolute values of UtA-PI were similar between nor-
mal, overweight and obese women at the 20-week scan
(Fig. 2a). The physiological drop in UtA-PI between 20 and
36 weeks was lower in obese women compared to women of
normal weight (mean drop −21.3% [95%CI −18.3, −24.2]
vs−25.7% [−24.3,−27.0], respectively, p < 0.001) (Table 2),
which remained after correction for maternal variables
including maternal BMI, systolic blood pressure at
12 weeks gestation, marital status, maternal age, maternal
ethnicity and deprivation index. This overall decrease in
physiological drop is due to a diminished fall in resistance
in the early phase (20–28 weeks), rather than the later phase
(28–36 weeks).
UtA-PI was higher throughout gestation for women car-
rying a male versus female fetus (Fig. 2b). Fetal sex did not
Fig. 1 Flow diagram showing
in- and exclusion criteria for
study into the influence of
maternal obesity and fetal sex
on cardiovascular adaptation
to pregnancy in the POPS
cohort. The final population
available for analysis was 3742
women. POPS; Pregnancy
Outcome Prediction Study, BMI
Body Mass Index.
2248 N. E. W. D. Teulings et al.
Table 1 Baseline and birth characteristics stratified by maternal BMI category.
Normal weight Overweight Obese Total
n= 2164 n= 1059 n= 519 n= 3742
Maternal age (y) 30.0 (4.8) 30.4 (5.3) 29.3 (5.7) 30.0 (5.1)
Gestational age at first scan 12.6 (0.8) 12.6 (0.8) 12.6 (0.9) 12.6 (0.9)
Gestational weight gain (kg)a
Total weight gain 12.4 (3.7) 12.8 (4.5) 10.8 (5.4) 12.3 (4.2)
From 12 to 20 weeks 3.4 (2.1) 3.2 (2.2) 2.6 (2.4) 3.2 (2.2)
From 20 to 28 week 4.7 (2.2) 4.9 (2.3) 4.0 (2.3) 4.6 (2.3)
From 28 to 36 weeks 4.3 (2.3) 4.6 (2.4) 4.2 (2.7) 4.4 (2.4)
Smoking status
Non-smoker 1381 (63.8%) 592 (55.9%) 266 (51.3%) 2239 (59.8%)
Quit pre-pregnancy 536 (24.8%) 330 (31.2%) 161 (31.0%) 1027 (27.4%)
Quit during pregnancy 143 (6.6%) 93 (8.8%) 58 (11.2%) 294 (7.9%)
Current smokers 104 (4.8%) 44 (4.2%) 34 (6.6%) 182 (4.9%)
Systolic BP (12 wkGA (mmHg)) 106.5 (11) 109.4 (11) 114.5 (11) 108.4 (11)
Fetal sex
Male 1090 (50.4%) 531 (50.1%) 264 (50.9%) 1885 (50.4%)
Female 1074 (49.6%) 528 (49.9%) 255 (49.1%) 1857 (49.6%)
Ethnicity
White 2027 (93.7%) 1005 (94.9%) 498 (96.0%) 3530 (94.3%)
Other 137 (6.3%) 54 (5.1%) 21 (4.0%) 212 (5.7%)
Marital status
Married 1535 (70.9%) 718 (67.8%) 316 (60.9%) 2569 (68.7%)
Not married 629 (29.1%) 341 (32.2%) 203 (39.1%) 1173 (31.3%)
Deprivation score
1 (lowest) 555 (25.6%) 282 (26.6%) 112 (21.6%) 949 (25.4%)
2 518 (23.9%) 276 (26.1%) 128 (24.7%) 922 (24.6%)
3 541 (25.0%) 271 (25.6%) 132 (25.4%) 944 (25.2%)
4 (highest) 550 (25.4%) 230 (21.7%) 147 (28.3%0 927 (24.8%)
Pre-existing diabetes
Yes 4 (0.2%) 10 (0.9%) 2 (0.4%) 16 (0.4%)
No 2160 (99.8%) 1049 (99.1%) 517 (99.6%) 3726 (99.6%)
Pre-existing hypertension
Yes 64 (3.0%) 68 (6.4%) 67 (12.9%) 199 (5.3%)
No 2100 (97.0%) 991 (93.6%) 452 (87.1%) 3543 (94.7%)
Gestational hypertension
Yes 24 (1.1%) 23 (2.2%) 20 (3.9%) 67 (1.8%)
No 2138 (98.8%) 1035 (97.7%) 499 (96.1%) 3672 (98.1%)
Unknown 2 (0.1%) 1 (0.1%) 0 (0.0%) 3 (0.1%)
Preeclampsia
Yes 95 (4.4%) 76 (7.2%) 84 (16.2%) 255 (6.8%)
No 2067 (95.5%) 982 (92.7%) 435 (83.8%) 3484 (93.1%)
Unknown 2 (0.1%) 1 (0.1%) 0 (0.0%) 3 (0.1%)
Gestational diabetes
Yes 58 (2.7%) 62 (5.9%) 57 (11.0%) 177 (4.7%)
No 2105 (97.3%) 993 (93.8%) 462 (89.0%) 3560 (95.1%)
Unknown 1 (0.0%) 4 (0.4%) 0 (0.0%) 5 (0.1%)
Birthweight (g) 3380 (498) 3444 (519) 3498 (569) 3414 (516)
Placental weight (g) 451 (93) 473 (102) 490 (489) 463 (99)
Data are represented as mean (SD) or as number (%). Differences in baseline characteristics were tested using chi-square tests and Kruskal–Wallis
tests.
BP blood pressure.
an-number for gestational weight gain at (i) 12–20wk; normal weight 2139, overweight 1048 and obese 515, (ii) 20–28wk; normal weight 2085,
overweight 1024 and obese 505, (iii) 28–36 wk; normal weight 1991, overweight 955 and obese 465, (iv) 12–36wk; normal weight 2021,
overweight 965 and obese 471.
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significantly influence the magnitude of the drop in uterine
artery PI over gestation (Supplementary Table 2). There was
no evidence of an interaction between fetal sex and maternal
BMI on UtA-PI over gestation (Supplementary Table 3).
Women carrying a female fetus had a higher UA-PI
throughout all of gestation compared to women carrying a
male fetus (Fig. 3b). The overall drop in UA-PI between 20
and 36 weeks was greater in women carrying a female fetus
compared to a male fetus (−32.5% [−31.5, −33.5] vs
−30.7% [−29.8, −31.7], respectively, p < 0.001) (Table 3).
We did not observe any differences in umbilical artery
pulsatility indices or the drop in UA-PI between maternal
BMI categories (Fig. 3a and Supplementary Table 4). We
did not find any sexual dimorphism in the relationship
between UA-PI and maternal pre-pregnancy BMI (Supple-
mentary Table 5).
A total of 5% of women had a UtA-PI value >95th
centile at 20 wkGA; 5.3% of normal-weight women were
above the reference range, while 4.9% of overweight and
4.0% of obese women had UtA-PI values above the 95th
centile at 20 wkGA (chi-square test p value= 0.50). At 28
wkGA, 5.0% of women had a UA-PI value about the 95th
centile; 4.4% of the women carrying a male fetus and 5.6%
of the women carrying a female fetus were above the
reference range (chi-square test p value= 0.28). The same
pattern was seen at 36 wkGA for a UA-PI value >95th
centile; 4.7% of all women, 4.3% of women carrying a
male fetus and 5.1% of women carrying a female fetus had
a UA-PI > 95th centile at 36 wkGA (chi-square test
p value= 0.78).
Results for the sensitivity analysis investigating the
influence of glucose levels at 28 weeks gestation or gesta-
tional weight gain, as well as excluding women with
gestational diabetes, preeclampsia, gestational hypertension
and preterm birth were unchanged from the main analysis
(Supplementary Tables 6–9).
Discussion
Main findings
We assessed the impact of maternal obesity and fetal sex
on both utero-placental and feto-placental resistance over
the course pregnancy, with the aim of improving under-
standing of the variability in risk of complications in
successive pregnancies. We show that resistance in the
utero-placental circulation is independently influenced by
both maternal BMI and fetal sex. The physiological drop
in uterine artery PI over the course of gestation was
attenuated in women who were overweight or obese
compared to women whose BMI was in the normal range.
The impact of maternal BMI on utero-placental resistance
became greater as the pregnancy progressed. By contrast,
the impact of fetal sex on utero-placental resistance was
consistent throughout gestation. Women carrying a
male fetus had consistently higher uterine artery doppler
PI compared to women carrying female fetuses at every
measured time-point.
Fig. 2 Physiological drop in uterine artery pulsatility index over
the course of gestation. a Development of uterine artery pulsatility
index (UtA-PI) over gestation stratified by maternal BMI category.
Absolute values at scanning timepoints [median (IQR)]; normal
weight-women; 20 wks [0.88 (0.72–1.09)], 28 wks [0.71 (0.61–0.84)],
36 wks [0.65 (0.56–0.77). Overweight women; 20 wks [0.88
(0.73–1.08)], 28 wks [0.73 (0.62–0.85)], 36 wks [0.66 (0.56–0.78)].
Obese women; 20wks [0.90 (0.74–1.09)], 28 wks [0.73 (0.63–0.88)],
36 wks [0.68 (0.59–0.82)]. Black; women with normal weight, dark
gray; overweight women, light gray; obese women. b Development of
UtA-PI over gestation stratified by fetal sex. Absolute values at
scanning timepoints [median (IQR)]; male fetuses; 20 wks [0.90
(0.74–1.10)], 28 wks [0.73 (0.62–0.86)], 36 wks [0.67 (0.58–0.78)].
Female fetuses; 20 wks [0.86 (0.71–1.07)], 28wks [0.71 (0.60–0.84)],
36 wks [0.65 (0.55–0.77)]. Dashed line; women carrying female fetus,
dotted line; women carrying male fetus. Estimates are simple observed
medians at each scanning time, statistics shown are from mixed linear
model corrected for gestational age. All p values are compared to
normal-weight women at same time period or women carrying a male
fetus at the same time period.
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Resistance in the feto-placental circulation was inde-
pendent of maternal BMI but influenced by fetal sex.
Pulsatility index in the umbilical artery was higher in
women carrying a female fetus compared to women car-
rying a male fetus at all time-points, but the magnitude of
difference between sexes reduced with increasing
gestation.
Previous studies have shown similar patterns when
investigating fetal sex differences in the absolute values of
UtA-PI in the second and third trimester [33], and
between maternal pre-pregnancy BMI and higher UtA-PI
in the third trimester [34]. However, in contrast to our
study, prior research did not assess the physiological
change in vascular resistance over the course of gestation
or a possible interaction between maternal BMI and
fetal sex.
Strengths and limitations
A major strength of the current work is the detailed phe-
notyping and completeness of the data available regarding
pregnancies in the POPS cohort [35]. In particular, long-
itudinal ultrasonographic measurements of both the uterine
and umbilical artery pulsatility indices from 20 weeks of
pregnancy through to 36 weeks are available on a large
cohort of nulliparous women. Moreover, the detailed set of
covariates in the POPS dataset allowed adjustment of our
models for other relevant maternal characteristics. A lim-
itation of our study is the lack of availability of other
Doppler parameters (e.g., resistance index) as well as the
lack of longitudinal blood pressure data, as previous studies
have shown a significant effect of maternal weight [36, 37]
as well as fetal sex [20] on the systolic and diastolic blood
pressure.
Interpretation
The adverse impact of higher maternal BMI on utero-
placental, but not feto-placental, vascular resistance dur-
ing pregnancy may reflect reduced baseline compliance in
the uterine (and other systemic) vasculature in women
with high BMI [8, 38]. Remodeling of the uterine vas-
culature is one of the major changes required to provide
adequate utero-placental perfusion to facilitate fetal
growth [39]. A failure to facilitate an adequate drop in the
UtA-PI is related to an increased incidence of placenta-
related diseases in the third trimester [40]. There is
extensive literature suggesting that obesity impairs nitric
oxide (NO) availability [reviewed in [41–43]], which
could reduce pregnancy-induced NO-mediated vasodila-
tion [44, 45], thus impairing the expected physiological
drop in vascular resistance during pregnancy in women
with higher BMIs. A further possibility is that spiralTa
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artery conversion, necessary to enable a low-resistance
vascular bed for exchange of nutrients and oxygen to the
fetus, is more likely to be incomplete in women with
higher BMI. Adequate spiral artery remodeling, via
extravillous trophoblast invasion, is required to facilitate
the normal physiological drop in utero-placental vascular
resistance over the course of gestation [46]. Spiral artery
remodeling is initiated by uterine natural killer cells,
which exhibit functional changes in gene expression and
growth factor signaling when exposed to maternal obesity
[47]. Higher BMI may therefore be associated with
incomplete spiral artery remodeling, and hence increased
utero-placental vascular resistance throughout gestation.
Few previous studies have examined differences in
utero-placental vascular resistance by fetal sex. Widnes and
colleagues reported no differences in uterine artery resis-
tance at 22–24 weeks gestation between fetal sexes [21],
whereas, Broere-Brown reported a systemically higher UtA-
PI in the second and third trimester in women carrying a
male fetus [33], consistent with the our findings. The
mechanism by which fetal sex can influence pulsatility
index in the uterine artery is not known, however, placental
sex has a profound effect on the placental transcriptome,
largely mediated by genes which escape from X chromo-
some inactivation. These differences include both pre-
viously recognized and placental-specific escapees and
these changes in turn alter the maternal serum metabolome
[17]. Hence, it is plausible that fetal sex may alter maternal
cardiovascular adaptation to pregnancy [48]. However,
there are also morphological differences in male versus fetal
placentas, for example placental weight, capillary density
and trophoblast differentiation [49, 50], which may be
reflected in a direct difference in placental vascular resis-
tance affecting flow in both the utero-placental and feto-
placental circulations.
Conclusions
Our analysis implies that higher BMI and male fetal sex are
independent risk factors for higher resistance in the uterine
artery, which act through distinct pathways. Previous
reports suggest that there is a higher incidence of placenta-
mediated pathologies, for example pre-eclampsia, in preg-
nancies with male rather than female fetuses [51], which
could be linked to the observed differences in utero-
placental and feto-placental blood flow. Furthermore,
maternal pre-pregnancy BMI is also a known risk factor for
pathologies linked to impaired utero-placental blood flow,
for example IUGR and pre-eclampsia [52, 53]. Our finding
that higher maternal BMI is associated with attenuation of
the physiological drop in pulsatility index of the uterine
artery across gestation provides impetus for further work
exploring interventions that can improve utero-placental
blood flow in mothers with higher BMI. Pulsatility index in
the uterine artery is a key predictor of adverse pregnancy
outcomes, such as preeclampsia and fetal growth restriction
[2, 54], hence our findings give new insight into the inde-
pendent risks posed by high maternal BMI and male
fetal sex.
Fig. 3 Physiological drop in the umbilical artery pulsatility index
over the course of gestation. a Development of umbilical artery
pulsatility index (UA-PI) over gestation stratified by maternal BMI
category. Absolute values at scanning timepoints [median (IQR)];
normal-weight women; 20 wks [1.25 (1.13–1.38)], 28 wks [1.04
(0.93–1.16)], 36 wks [0.86 (0.76–0.97)]. Overweight women; 20 wks
[1.25 (1.14–1.37)], 28 wks [1.05 (0.94–1.16)], 36 wks [0.85
(0.74–0.97)]. Obese women; 20wks [1.26 (1.13–1.37)], 28 wks [1.07
(0.95–1.18)], 36 wks [0.85 (0.75–0.96)]. Black; women with normal
weight, dark gray; overweight women, light gray; obese women.
b Development of UA-PI over gestation stratified by fetal sex.
Absolute values at scanning timepoints [median (IQR)]; male fetuses;
20wks [1.22 (1.11–1.34)], 28wks [1.03 (0.92–1.14)], 36 wks [0.85
(0.75–0.96)]. Female fetuses; 20 wks [1.28 (1.16–1.40)], 28 wks [1.07
(0.96–1.20)], 36 wks [0.87 (0.76–0.98)]. Dashed line; women carrying
female fetus, dotted line; women carrying male fetus. Estimates are
simple observed medians at each scanning time, statistics shown are
from mixed linear model corrected for gestational age. All p values are
compared to normal-weight women at same time period or women
carrying a male fetus at the same time period.
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